Cookies & Privacy

We use essential cookies to make our site work. With your permission, we’ll also use analytics and marketing cookies to improve your experience. You can change your choice anytime.

See our Privacy Policy for details.

Manage preferences
Cookie preferences
Back to Industry News
General

Dexcom Restructures, Cuts 350 Jobs Globally

Summary generated with AI, editor-reviewed
Heartspace News Desk
Source: Medtech Magazine

Key takeaways

  • Medtech Magazine reports that Dexcom, a medical technology company specializing in diabetes management, is implementing a significant organizational restructuring
  • This initiative will lead to the elimination of 350 positions globally, a workforce reduction representing approximately three percent of the company's total employee base
  • The majority of these layoffs, exceeding fifty percent, will take place at Dexcom's corporate headquarters in San Diego, California
Medtech Magazine reports that Dexcom, a medical technology company specializing in diabetes management, is implementing a significant organizational restructuring. This initiative will lead to the elimination of 350 positions globally, a workforce reduction representing approximately three percent of the company's total employee base. The majority of these layoffs, exceeding fifty percent, will take place at Dexcom's corporate headquarters in San Diego, California. While Dexcom maintains international operations in countries such as Austria, Canada, Germany, Switzerland, and the United Kingdom, specific impacts in these regions were not detailed. A Dexcom spokesperson explained that these job cuts are a direct result of fundamental changes to the company's organizational model and operational structure. This action follows a substantial savings initiative implemented by Dexcom last year, which resulted in the dismissal of over 500 employees. The current restructuring is positioned as a continuation of the company's ongoing efforts to refine its operational framework.

Related Topics

Dexcomlayoffsrestructuringmedical technologydiabetes sectorworkforce reduction

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original